TARO-TICAGRELOR

Identification of Taro-Ticagrelor

No description

Google image searchProduct monograph

Active ingredient

ticagrelor, 60 MG

DIN: 02492571

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 31-MAY-2022

ATC:

• B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
• B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
• B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
• B01AC24 — TICAGRELOR (ATC/DDD)

Reference brand drug: Brilinta

External Links for Taro-Ticagrelor

Search on Google

• Taro-Ticagrelor side effects
• Taro-Ticagrelor dosage
• ticagrelor side effects
• ticagrelor dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-ticagrelor photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.